• Info
  • Insider Ownership

Insider Trading & Ownership of Jane A. Gross

Location
Seattle, WA
Summary
The estimated net worth of Jane A. Gross is at least $39,000 dollars as of 02 May 2025. Jane A. Gross is the Director of aTYR PHARMA INC and owns shares of aTYR PHARMA INC (ATYR) stock worth about $39K.
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jane A. Gross and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Jane A. Gross has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $39,000.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: aTYR PHARMA INC ($39,000).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jane A. Gross

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATYR aTYR PHARMA INC Director $39,000 01 May 2025
BCTX, BCTXL BriaCell Therapeutics Corp. Director 01 Aug 2022

Insider Transactions Reported by Jane A. Gross:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored